HB5329 EngrossedLRB104 20662 KTG 34160 b

1    AN ACT concerning health.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Mental Health and Developmental
5Disabilities Code is amended by changing Sections 1-109,
61-129, 2-107, 2-107.1, 3-611, and 3-807 and by adding Section
71-103.5 as follows:
 
8    (405 ILCS 5/1-103.5 new)
9    Sec. 1-103.5. Confinement. "Confinement", with respect to
10a mental health facility, means that an individual is
11prevented or otherwise not permitted to leave the facility.
 
12    (405 ILCS 5/1-109)  (from Ch. 91 1/2, par. 1-109)
13    Sec. 1-109. "Discharge" means the full and physical
14release of any person admitted or otherwise detained under
15this Act from treatment, habilitation, or care and custody.
16(Source: P.A. 80-1414.)
 
17    (405 ILCS 5/1-129)
18    Sec. 1-129. Mental illness. "Mental illness" means a
19mental, or emotional disorder that substantially impairs a
20person's thought, perception of reality, emotional process,
21judgment, behavior, or ability to cope with the ordinary

 

 

HB5329 Engrossed- 2 -LRB104 20662 KTG 34160 b

1demands of life, but does not include a developmental
2disability, a neurocognitive disorder dementia or Alzheimer's
3disease absent psychosis, a substance use disorder, or an
4abnormality manifested only by repeated criminal or otherwise
5antisocial conduct.
6(Source: P.A. 100-759, eff. 1-1-19.)
 
7    (405 ILCS 5/2-107)  (from Ch. 91 1/2, par. 2-107)
8    Sec. 2-107. Refusal of services; informing of risks.
9    (a) An adult recipient of services or the recipient's
10guardian, if the recipient is under guardianship, and the
11recipient's substitute decision maker, if any, must be
12informed of the recipient's right to refuse medication or
13electroconvulsive therapy. The recipient and the recipient's
14guardian or substitute decision maker shall be given the
15opportunity to refuse generally accepted mental health or
16developmental disability services, including but not limited
17to medication or electroconvulsive therapy. If such services
18are refused, they shall not be given unless such services are
19necessary to prevent the recipient from causing serious and
20imminent physical harm to the recipient or others and no less
21restrictive alternative is available. The facility director
22shall inform a recipient, guardian, or substitute decision
23maker, if any, who refuses such services of alternate services
24available and the risks of such alternate services, as well as
25the possible consequences to the recipient of refusal of such

 

 

HB5329 Engrossed- 3 -LRB104 20662 KTG 34160 b

1services.
2    (b) Psychotropic medication or electroconvulsive therapy
3may be administered under this Section for up to 24 hours only
4if the circumstances leading up to the need for emergency
5treatment are set forth in writing in the recipient's record.
6    (c) Administration of medication or electroconvulsive
7therapy may not be continued unless the need for such
8treatment is redetermined at least every 24 hours based upon a
9personal examination of the recipient by a physician or a
10nurse under the supervision of a physician and the
11circumstances demonstrating that need are set forth in writing
12in the recipient's record.
13    (d) Neither psychotropic medication nor electroconvulsive
14therapy may be administered under this Section for a period in
15excess of 72 hours, excluding Saturdays, Sundays, and
16holidays, unless a petition is filed under Section 2-107.1 and
17the treatment continues to be necessary under subsection (a)
18of this Section. Once the petition has been filed, treatment
19may continue in compliance with subsections (a), (b), and (c)
20of this Section until the final outcome of the hearing on the
21petition.
22    (e) The Department shall issue rules designed to ensure
23insure that in State-operated mental health facilities
24psychotropic medication and electroconvulsive therapy are
25administered in accordance with this Section and only when
26appropriately authorized and monitored by a physician or a

 

 

HB5329 Engrossed- 4 -LRB104 20662 KTG 34160 b

1nurse under the supervision of a physician in accordance with
2accepted medical practice. The facility director of each
3mental health facility not operated by the State shall issue
4rules designed to ensure insure that in that facility
5psychotropic medication and electroconvulsive therapy are
6administered in accordance with this Section and only when
7appropriately authorized and monitored by a physician or a
8nurse under the supervision of a physician in accordance with
9accepted medical practice. Such rules shall be available for
10public inspection and copying during normal business hours.
11    (f) The provisions of this Section with respect to the
12emergency administration of psychotropic medication and
13electroconvulsive therapy do not apply to facilities licensed
14under the Nursing Home Care Act, the Specialized Mental Health
15Rehabilitation Act of 2013, the ID/DD Community Care Act, or
16the MC/DD Act.
17    (g) Under no circumstances may long-acting psychotropic
18medications be administered under this Section.
19    (h) Whenever psychotropic medication or electroconvulsive
20therapy is refused pursuant to subsection (a) of this Section
21at least once that day, the physician or advanced practice
22psychiatric nurse shall determine and state in writing the
23reasons why the recipient did not meet the criteria for
24administration of medication or electroconvulsive therapy
25under subsection (a) and whether the recipient meets the
26standard for administration of psychotropic medication or

 

 

HB5329 Engrossed- 5 -LRB104 20662 KTG 34160 b

1electroconvulsive therapy under Section 2-107.1 of this Code.
2If the physician or advanced practice psychiatric nurse
3determines that the recipient meets the standard for
4administration of psychotropic medication or electroconvulsive
5therapy under Section 2-107.1, the facility director or his or
6her designee shall petition the court for administration of
7psychotropic medication or electroconvulsive therapy pursuant
8to that Section unless the facility director or his or her
9designee states in writing in the recipient's record why the
10filing of such a petition is not warranted. This subsection
11(h) applies only to State-operated mental health facilities.
12    (i) The Department shall conduct annual trainings for all
13physicians and registered nurses working in State-operated
14mental health facilities on the appropriate use of emergency
15administration of psychotropic medication and
16electroconvulsive therapy, standards for their use, and the
17methods of authorization under this Section.
18(Source: P.A. 98-104, eff. 7-22-13; 99-180, eff. 7-29-15.)
 
19    (405 ILCS 5/2-107.1)  (from Ch. 91 1/2, par. 2-107.1)
20    Sec. 2-107.1. Administration of psychotropic medication
21and electroconvulsive therapy upon application to a court.
22    (a) (Blank).
23    (a-5) Notwithstanding the provisions of Section 2-107 of
24this Code, psychotropic medication and electroconvulsive
25therapy may be administered to an adult recipient of services

 

 

HB5329 Engrossed- 6 -LRB104 20662 KTG 34160 b

1on an inpatient or outpatient basis without the informed
2consent of the recipient under the following standards:
3        (1) Any person 18 years of age or older, including any
4    guardian, may petition the circuit court for an order
5    authorizing the administration of psychotropic medication
6    and electroconvulsive therapy to a recipient of services.
7    The petition shall state that the petitioner has made a
8    good faith attempt to determine whether the recipient has
9    executed a power of attorney for health care under the
10    Powers of Attorney for Health Care Law or a declaration
11    for mental health treatment under the Mental Health
12    Treatment Preference Declaration Act and to obtain copies
13    of these instruments if they exist. If either of the
14    above-named instruments is available to the petitioner,
15    the instrument or a copy of the instrument shall be
16    attached to the petition as an exhibit. The petitioner
17    shall deliver a copy of the petition, and notice of the
18    time and place of the hearing, to the respondent, his or
19    her attorney, any known agent or attorney-in-fact, if any,
20    and the guardian, if any, no later than 3 days prior to the
21    date of the hearing. Service of the petition and notice of
22    the time and place of the hearing may be made upon parties
23    other than the respondent by transmitting them via
24    facsimile machine or by operation of an electronic filing
25    manager service authorized by the Supreme Court. Service
26    of the petition and notice of the time and place of the

 

 

HB5329 Engrossed- 7 -LRB104 20662 KTG 34160 b

1    hearing upon a respondent may be accomplished by any one
2    of the following:
3            (A) Personal service.
4            (B) Handing a copy of the petition and notice to
5        the respondent together with a waiver of personal
6        service. The waiver may be returned to the party
7        delivering the petition and notice. If the party
8        delivering the petition and notice to the respondent
9        does not receive the waiver, the service must be by
10        personal service.
11            (C) If the respondent is confined to a mental
12        health facility, handing a copy of the petition and
13        notice to the respondent, provided the party
14        delivering the petition and notice to the respondent
15        files within 24 hours a verified statement naming the
16        party served and stating the means, place, date, and
17        time of service. If no verification of service is
18        filed before the matter is set for hearing, then
19        service must be made by personal service. to the
20        respondent or other party. Upon receipt of the
21        petition and notice, the party served, or the person
22        delivering the petition and notice to the party
23        served, shall acknowledge service. If the party
24        sending the petition and notice does not receive
25        acknowledgement of service within 24 hours, service
26        must be made by personal service.

 

 

HB5329 Engrossed- 8 -LRB104 20662 KTG 34160 b

1        A petition requesting that the court authorize
2    treatment with psychotropic medication shall specify the
3    full names of the medications and anticipated range of
4    dosage that comprise such treatment. The petition also may
5    include a request that the court authorize alternative or
6    alternate treatments with psychotropic medications, but
7    only where the petition sets forth the psychotropic
8    medications and the anticipated range of dosages for each
9    alternative or alternate and each combination of
10    psychotropic medications that may be administered
11    simultaneously.
12        The petition may include a request that the court
13    authorize such testing and procedures as may be essential
14    for the safe and effective administration of the
15    psychotropic medication or electroconvulsive therapy
16    sought to be administered, but only where the petition
17    sets forth the specific testing and procedures sought to
18    be administered.
19        If a hearing is requested to be held immediately
20    following the hearing on a petition for involuntary
21    admission, then the notice requirement shall be the same
22    as that for the hearing on the petition for involuntary
23    admission, and the petition filed pursuant to this Section
24    shall be filed with the petition for involuntary
25    admission.
26        (2) The court shall hold a hearing within 7 days of the

 

 

HB5329 Engrossed- 9 -LRB104 20662 KTG 34160 b

1    filing of the petition. The People, the petitioner, or the
2    respondent shall be entitled to a continuance of up to 7
3    days as of right. An additional continuance of not more
4    than 7 days may be granted to any party (i) upon a showing
5    that the continuance is needed in order to adequately
6    prepare for or present evidence in a hearing under this
7    Section or (ii) under exceptional circumstances. The court
8    may grant an additional continuance not to exceed 21 days
9    when, in its discretion, the court determines that such a
10    continuance is necessary in order to provide the recipient
11    with an examination pursuant to Section 3-803 or 3-804 of
12    this Act, to provide the recipient with a trial by jury as
13    provided in Section 3-802 of this Act, or to arrange for
14    the substitution of counsel as provided for by the
15    Illinois Supreme Court Rules. The hearing shall be
16    separate from a judicial proceeding held to determine
17    whether a person is subject to involuntary admission but
18    may be heard immediately preceding or following such a
19    judicial proceeding and may be heard by the same trier of
20    fact or law as in that judicial proceeding.
21        (3) Unless otherwise provided herein, the procedures
22    set forth in Article VIII of Chapter III of this Act,
23    including the provisions regarding appointment of counsel,
24    shall govern hearings held under this subsection (a-5).
25        (4) Psychotropic medication and electroconvulsive
26    therapy may be administered to the recipient if and only

 

 

HB5329 Engrossed- 10 -LRB104 20662 KTG 34160 b

1    if it has been determined by clear and convincing evidence
2    that: all of the following factors are present. In
3    determining whether a person meets the criteria specified
4    in the following paragraphs (A) through (G), the court may
5    consider evidence of the person's history of serious
6    violence, repeated past pattern of specific behavior,
7    actions related to the person's illness, or past outcomes
8    of various treatment options.
9            (A) That the recipient has a serious mental
10        illness or developmental disability; .
11            (B) That because of said mental illness or
12        developmental disability, the recipient currently
13        exhibits any one of the following: (i) deterioration
14        of his or her ability to function, as compared to the
15        recipient's ability to function prior to the current
16        onset of symptoms of the mental illness or disability
17        for which treatment is presently sought, (ii)
18        suffering, or (iii) threatening behavior; .
19            (C) That the illness or disability has existed for
20        a period marked by the continuing presence of the
21        symptoms set forth in item (B) of this subdivision (4)
22        or the repeated episodic occurrence of these
23        symptoms; .
24            (D) That the benefits of the treatment outweigh
25        the harm; .
26            (E) That the recipient lacks the capacity to make

 

 

HB5329 Engrossed- 11 -LRB104 20662 KTG 34160 b

1        a reasoned decision about the treatment; .
2            (F) That other less restrictive services have been
3        explored and found inappropriate; and .
4            (G) if If the petition seeks authorization for
5        testing and other procedures, that such testing and
6        procedures are essential for the safe and effective
7        administration of the treatment.
8        (4.5) In determining whether there is clear and
9    convincing evidence, the court may consider evidence
10    presented, if any, about a recipient's history of serious
11    violence, repeated past pattern of specific behavior
12    related to the recipient's illness, or outcomes of past
13    treatments.
14        (5) In no event shall an order issued under this
15    Section be effective for more than 90 days. A second
16    90-day period of involuntary treatment may be authorized
17    pursuant to a hearing that complies with the standards and
18    procedures of this subsection (a-5). Thereafter,
19    additional 180-day periods of involuntary treatment may be
20    authorized pursuant to the standards and procedures of
21    this Section without limit. If a new petition to authorize
22    the administration of psychotropic medication or
23    electroconvulsive therapy is filed at least 15 days prior
24    to the expiration of the prior order, and if any
25    continuance of the hearing is agreed to by the recipient,
26    the administration of the treatment may continue in

 

 

HB5329 Engrossed- 12 -LRB104 20662 KTG 34160 b

1    accordance with the prior order pending the completion of
2    a hearing under this Section.
3        (6) An order issued under this subsection (a-5) shall
4    designate the persons authorized to administer the
5    treatment under the standards and procedures of this
6    subsection (a-5). Those persons shall have complete
7    discretion not to administer any treatment authorized
8    under this Section. The order shall also specify the
9    medications and the anticipated range of dosages that have
10    been authorized and may include a list of any alternative
11    medications and range of dosages deemed necessary. In
12    addition, the order may authorize the administration of
13    any alternative or alternate treatment that is requested
14    in the petition and for which the court finds clear and
15    convincing evidence that the benefits of the alternative
16    or alternate treatment outweigh the harm and the recipient
17    lacks the capacity to make a reasoned decision about the
18    treatment. The medications and the anticipated range of
19    dosages for any alternative or alternate treatment that
20    the court authorizes shall be included in the order. Where
21    the simultaneous use of multiple psychotropic medications
22    is authorized, the order shall specify the combinations
23    that are authorized.
24    (a-10) The court may, in its discretion, appoint a
25guardian ad litem for a recipient before the court or
26authorize an existing guardian of the person to monitor

 

 

HB5329 Engrossed- 13 -LRB104 20662 KTG 34160 b

1treatment and compliance with court orders under this Section.
2    (b) A guardian may be authorized to consent to the
3administration of psychotropic medication or electroconvulsive
4therapy to an objecting recipient only under the standards and
5procedures of subsection (a-5).
6    (c) Notwithstanding any other provision of this Section, a
7guardian may consent to the administration of psychotropic
8medication or electroconvulsive therapy to a non-objecting
9recipient under Article XIa of the Probate Act of 1975.
10    (d) Nothing in this Section shall prevent the
11administration of psychotropic medication or electroconvulsive
12therapy to recipients in an emergency under Section 2-107 of
13this Act.
14    (e) Notwithstanding any of the provisions of this Section,
15psychotropic medication or electroconvulsive therapy may be
16administered pursuant to a power of attorney for health care
17under the Powers of Attorney for Health Care Law or a
18declaration for mental health treatment under the Mental
19Health Treatment Preference Declaration Act over the objection
20of the recipient if the recipient has not revoked the power of
21attorney or declaration for mental health treatment as
22provided in the relevant statute.
23    (f) The Department shall conduct annual trainings for
24physicians and registered nurses working in State-operated
25mental health facilities on the appropriate use of
26psychotropic medication and electroconvulsive therapy,

 

 

HB5329 Engrossed- 14 -LRB104 20662 KTG 34160 b

1standards for their use, and the preparation of court
2petitions under this Section before any such psychiatrists or
3advanced practice psychiatric nurses may petition the court or
4testify at a hearing under this Section.
5(Source: P.A. 100-710, eff. 8-3-18.)
 
6    (405 ILCS 5/3-611)  (from Ch. 91 1/2, par. 3-611)
7    Sec. 3-611. Filing petition, first certificate, and proof
8of service.
9    (a) Within 24 hours, excluding Saturdays, Sundays and
10holidays, after the respondent's admission under this Article,
11the facility director of the facility shall file 2 copies of
12the petition, the first certificate, and proof of service of
13the petition and statement of rights upon the respondent with
14the court in the county in which the facility is located.
15    (b) Upon completion of the second certificate, the
16facility director shall promptly file it with the court and
17provide a copy to the respondent.
18    (c) The facility director shall make copies of the
19certificates available to the attorneys for the parties upon
20request.
21    (d) Upon the filing of the petition and first certificate,
22the court shall set a hearing to be held within 5 days,
23excluding Saturdays, Sundays and holidays, after receipt of
24the petition. The court shall direct that notice of the time
25and place of the hearing be served upon the respondent, his

 

 

HB5329 Engrossed- 15 -LRB104 20662 KTG 34160 b

1responsible relatives, and the persons entitled to receive a
2copy of the petition pursuant to Section 3-609.
3    (e) For purposes of this Section, (1) a respondent is
4admitted to a mental health facility at the earlier of the
5respondent's confinement or receipt of treatment and (2) a
6respondent who is ordered discharged in accordance with
7Section 3-809 or subsection (b) of Section 3-901, or
8discharged upon notice by the facility director as provided by
9subsection (a) of Section 3-903, remains admitted to a mental
10health facility until the respondent is physically released
11from the mental health facility and thereafter physically
12enters a mental health facility.
13(Source: P.A. 98-865, eff. 8-8-14.)
 
14    (405 ILCS 5/3-807)  (from Ch. 91 1/2, par. 3-807)
15    Sec. 3-807. Testimony. No respondent may be found subject
16to involuntary admission on an inpatient or outpatient basis
17unless at least one psychiatrist, clinical social worker,
18clinical psychologist, advanced practice psychiatric nurse, or
19qualified examiner who has examined the respondent testifies
20in person at the hearing. No administration of psychotropic
21medication or electroconvulsive therapy without the informed
22consent of the recipient may be authorized unless at least one
23psychiatrist or advanced practice psychiatric nurse who has
24examined the recipient testifies in person at the hearing. The
25respondent may waive the requirement of the testimony subject

 

 

HB5329 Engrossed- 16 -LRB104 20662 KTG 34160 b

1to the approval of the court.
2(Source: P.A. 101-587, eff. 1-1-20.)